• Tech
• Gadgets
• Mobile
• Enterprise
• CrunchBase
• More
  • Beta Invites
  • Elevator Pitches
  • Gillmor Gang
  • Podcasts
  • TechCrunch50
  • TechCrunch UK
  • TechCrunch France
  • TechCrunch Japan

iPierian

edit

We are using induced pluripotent stem cells for drug discovery and development. Focused on neurodegenerative diseases such as SMA, ALS and Parkinson’s, and other major unmet medical needs.

Milestones

edit

• 
  iPierian received $3.7M in Unattributed funding. (10/09)
  Posted 10/26/09 at 5:47pm
• 
  iPierian received $11.5M in Unattributed funding. (7/8/09)
  Posted 9/28/09 at 2:14am
• 
  iPierian acquired iZumi Bio. (7/8/09)
  Posted 9/28/09 at 2:11am

Videos

Screenshots

edit

Above: iPierian Screenshot -- #1
Uploaded: 9/28/09

Sources

1. iZumi Bio and Pierian Merge to Form iPierian to Advance Cellular Reprogramming (biocetera.com) [edit]
2. iZumi Bio and Pierian Merge to Form iPierian to Advance Cellular Reprogramming (biocetera.com) [edit]
3. iPierian snags $3.7M grant from NIH for cell reprogramming (deals.venturebeat.com) [edit]